Surfactant treatment for acute respiratory distress syndrome

Archives of Disease in Childhood

Volumn 80, Issue 3, 1999, Pages 248-252

  López Herce, Jesus ^a   De Lucas, Nieves ^a   Carrillo, Angel ^a   Bustinza, Amaya ^a   Moral, Ramon ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Acute respiratory distress syndrome; Lung disease; Surfactant

Indexed keywords

LUNG SURFACTANT;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HUMAN; INFANT; LUNG DISEASE; LUNG VENTILATION PERFUSION RATIO; MALE; OXYGENATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY DISTRESS SYNDROME; SURVIVAL RATE; SYSTEMIC DISEASE;

EID: 0033017409     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.80.3.248     Document Type: Article

References (32)

1. 1 Bernard GR, Artigas A3 Brigham KL, et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Med 1994;20:225-32.
2. 2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994;149: 295-305.
3. 3 Hicling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med 1994;22: 1568-78.
4. 4 Murdoch IA, Storman MO. Improved arterial oxygenation in children with the adult respiratory distress syndrome: the prone position. Acta Paediatr 1994;83:1043-6.
5. 5 Arnold JH, Hanson JH, Toro-Figuero LO, Gutierrez J, Berens RJ, Anglin DL. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 1994;22:1530-9.
6. 6 Rosaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
7. 7 López-Herce J, Cueto F., Carrillo A, Vázquez P, Bustinza A, Moral R. Respuesta aguda a la administración de óxido nítrico en niǹos. An Esp Pediatr 1997;46:581-586.
8. 8 Moler FW, Custer JR, Barlett RH, et al. Extracorporeal life support for severe pediatric respiratory failure; an update experience 1991-1993. J Pediatr 1994;124;875-80.
9. 9 DeBruin W, Notterman DA, Magid M, Godwin T, Johnston S. Acute hypoxemic respiratory failure in infants and children: clinical and pathologic characteristics. Crit Care Med 1992;20:1223-34.
10. 10 Davis SL, Furman DP, Costarino AT. Adult respiratory distress syndrome in children: associated disease, clinical course, and predictors of death. J Pediatr 1993;123:35-45.
11. 11 Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993;147:218-33.
12. 12 Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88:1976-81.
13. 13 Collaborative European Multicenter Study Group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics 1988;82:683-91.
14. 14 Gommers D, Lachmann B. Surfactant therapy in the adult patient. Curr Opin Crit Care 1995;1:57-61.
15. 15 Haslam PL, Hughes DA, MacNaughton PD, Baker CS, Evans TW. Surfactant replacement therapy in late-stage adult respiratory distress syndrome. Lancet 1994;343: 1009-11.
16. 16 Anzueto A, Baughman RP, Guntupalli KK, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996;334:1417-21.
17. 17 Gregory TJ, Gadek JE, Weiland JE, et al. Survanta supplementation in patients with acute respiratory distress syndrome (ARDS) [abstract]. Am J Respir Crit Care Med 1994;149:A567.
18. 18 Lachmann B. The role of pulmonary surfactant in the pathogenesis and therapy of ARDS. In: Vincent JL, ed. Update in intensive care and emergence medicine. Berlin: Springer-Verlag, 1987:123-34.
19. 19 Marraro G, Casiraghi G, collaborative study group on surfactant replacement in infants. Porcine natural surfactant in infants with adult respiratory distress syndrome (ARDS). Pediatr Res 1995;37:287.
20. 20 Aldamiz-Echevarria L, Rodriguez J, Arana J, Emparanza JI, Izquierdo MA, Landa J. Presentación de un lactante afecto de distrés respiratorio tipo adulto y tratado con surfactante pulmonar. An Esp Pediatr 1994,40:311-12.
21. 21 Wilson DF, Jiao JH, Bauman LA, et al. Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med 1996:24:1316-22.
22. 22 Moreno M, López-Herce J, Merello C, Alcaraz A, Carrillo A. Exogenous surfactant therapy for acute respiratory distress in infancy. Intensive Care Med 1996;22:87.
23. 23 McGowan FX, Ikegami M, Del Nido PJ, et al. Cardiopulmonary bypass significantly reduces surfactant activity in children. J Thorac Cardiovasc Surg 1993;106:968-77.
24. 24 LeVine AM, Lotze A, Stanley S. Surfactant content in children with inflammatory lung disease. Crit Care Med 1996; 24:1062-7.
25. 25 Do Campo JL, Bertarnou EG, De Lorenzi A, Hager AA. Nebulised exogenous natural surfactant after cardiac surgery. Lancet 1994:343:482.
26. 26 Macnaughton PD, Evans TW. The effect of exogenous surfactant therapy on lung function following cardiopulmonary bypass. Chest 1994:105:421-5.
27. 27 Lewis JE, Veldhuizen RAW. Factors influencing efficacy of exogenous surfactant in acute lung injury. Biol Neonate 1995;67(suppl 1):48-60.
28. 28 Cummings JJ, Holm BA, Hudak ML, Hudak BB, Ferguson WH, Egan EA. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis 1992:145:999-1004.
29. 29 Van der Bleek J, Plötz FB, van Overbeek M, et al. Distribution of exogenous surfactant in rabbits with severe respiratory failure: the effect of volume. Pediatr Res 1993:34: 154-8.
30. 30 Evans DA, Wilmott RW, Whitsett JA. Surfactant replacement therapy for adult respiratory distress syndrome in children. Pediatr Pulmonol 1996;21.328-36.
31. 31 Segerer H, Scheid A, Wagner M, Obladen M. Tracheal surfactant infusion during 5 minutes is less effective than bolus instillation in rabbits [abstract]. Pediatr Res 1994;36: 37A.
32. 32 Gregory GA, Phibbs RH. Surfactant replacement for respiratory failure: lessons from the neonate. Anesth Analg 1993-76:465-6.